» Articles » PMID: 38457211

Phenome-wide Association Study of Ovarian Cancer Identifies Common Comorbidities and Reveals Shared Genetics with Complex Diseases and Biomarkers

Overview
Journal Cancer Med
Specialty Oncology
Date 2024 Mar 8
PMID 38457211
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ovarian cancer (OC) is commonly diagnosed among older women who have comorbidities. This hypothesis-free phenome-wide association study (PheWAS) aimed to identify comorbidities associated with OC, as well as traits that share a genetic architecture with OC.

Methods: We used data from 181,203 white British female UK Biobank participants and analysed OC and OC subtype-specific genetic risk scores (OC-GRS) for an association with 889 diseases and 43 other traits. We conducted PheWAS and colocalization analyses for individual variants to identify evidence for shared genetic architecture.

Results: The OC-GRS was associated with 10 diseases, and the clear cell OC-GRS was associated with five diseases at the FDR threshold (p = 5.6 × 10 ). Mendelian randomizaiton analysis (MR) provided robust evidence for the association of OC with higher risk of "secondary malignant neoplasm of digestive systems" (OR 1.64, 95% CI 1.33, 2.02), "ascites" (1.48, 95% CI 1.17, 1.86), "chronic airway obstruction" (1.17, 95% CI 1.07, 1.29), and "abnormal findings on examination of the lung" (1.51, 95% CI 1.22, 1.87). Analyses of lung spirometry measures provided further support for compromised respiratory function. PheWAS on individual OC variants identified five genetic variants associated with other diseases, and seven variants associated with biomarkers (all, p ≤ 4.5 × 10 ). Colocalization analysis identified rs4449583 (from TERT locus) as the shared causal variant for OC and seborrheic keratosis.

Conclusions: OC is associated with digestive and respiratory comorbidities. Several variants affecting OC risk were associated with other diseases and biomarkers, with this study identifying a novel genetic locus shared between OC and skin conditions.

Citing Articles

Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkers.

Mulugeta A, Lumsden A, Madakkatel I, Stacey D, Lee S, Maenpaa J Cancer Med. 2024; 13(4):e7051.

PMID: 38457211 PMC: 10923028. DOI: 10.1002/cam4.7051.


RETRACTED: Modern Subtype Classification and Outlier Detection Using the Attention Embedder to Transform Ovarian Cancer Diagnosis.

Nobel S, Swapno S, Hossain M, Safran M, Alfarhood S, Kabir M Tomography. 2024; 10(1):105-132.

PMID: 38250956 PMC: 11154515. DOI: 10.3390/tomography10010010.

References
1.
Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

2.
Phelan C, Kuchenbaecker K, Tyrer J, Kar S, Lawrenson K, Winham S . Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017; 49(5):680-691. PMC: 5612337. DOI: 10.1038/ng.3826. View

3.
Lee L, Cheung W, Atkinson E, Krzyzanowska M . Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2010; 29(1):106-17. DOI: 10.1200/JCO.2010.31.3049. View

4.
Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J . Cytoreductive surgery in ovarian cancer. Cancer Imaging. 2007; 7:210-5. PMC: 2151328. DOI: 10.1102/1470-7330.2007.0030. View

5.
Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View